Status and phase
Conditions
Treatments
About
Determine the efficacy of dexamethasone plus standard of care (SOC) as compared to placebo plus SOC for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype; It's an international phase III, double-blind, placebo-controlled, randomized trial.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
450 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Lucile MARGUET; Antoine ROQUILLY
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal